Mark A. Watson

29.9k citations

129 papers · 7.2k indexed · h-index 48

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 19
Oncology top 1%
- Cancer Cells and Metastasis 21
Molecular Biology top 2%
- Molecular Biology Techniques and Applications 14
- RNA modifications and cancer 9
- Gene expression and cancer classification 9
Pathology and Forensic Medicine top 1%
- Genetic factors in colorectal cancer 8
Pulmonary and Respiratory Medicine top 1%
Genetics
- Estrogen and related hormone effects 9
- Glioma Diagnosis and Treatment 8

Co-authors: Jeffrey Milbrandt Timothy P. Fleming David H. Gutmann Arie Perry Rakesh Nagarajan Toshiyuki Araki John Svaren Torsten Ehrig
Cited by: Cancer Research Oncology Molecular Biology
Journals: Journal of Clinical Oncology (14 papers)Cancer Research (9 papers)Clinical Cancer Research (8 papers)
Partner nations: United States Canada France

In The Last Decade

Mark A. Watson

123 papers receiving 7.1k citations

Peers

Countries citing papers authored by Mark A. Watson

Since Specialization

Citations

This map shows the geographic impact of Mark A. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Watson more than expected).

Fields of papers citing papers by Mark A. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Watson. The network helps show where Mark A. Watson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark A. Watson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Watson Line = papers co-authored together Mark A. Watson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Adjuvant Dose-Dense Chemotherapy in Hormone Receptor–Positive Breast Cancer Journal of Clinical Oncology ·Otto Metzger,Karla V. Ballman,Hartmut Rohlfing,Minetta C. Liu,Jennifer A. Ligibel,Mark A. Watson,Eveline Chen,Philomena N. Lumumba,Daniel G. Stover,Lisa A. Carey,Ann H. Partridge,Jeffrey Kirshner,Hyman B. Muss,Clifford A. Hudis,Eric P. Winer,Larry Norton,W. Fraser Symmans	2025	1
2	A pre-vaccination immune metabolic interplay determines the protective antibody response to a dengue virus vaccine Cell Reports ·Pallavi Chaurasia,李先鎬,Abdullah M. Izmirly,Mark A. Watson,Tiziana Di Pucchio,Karina I. Carvalho,Abdelali Filali-Mouhim,Eustache Paramithiotis,María do Carmo Sampaio Tavares Timenetsky,Alexander Roberto Precioso,Jorge Kalil,Michael Diamond,Elias K. Haddad,Esper G. Kallás,Rafick‐Pierre Sékaly	2024	0
3	Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502 npj Breast Cancer ·Daniel G. Stover,Roberto Salgado,Jamile Mascarenhas Senhorinho,Karla V. Ballman,Erica L. Mayer,Mark Jesus M. Magbanua,Sherene Loi,てる子赤坂,Carolina E. Viswanath,Mark A. Watson,Yujia Wen,W. Fraser Symmans,Charles M. Perou,Lisa A. Carey,Ann H. Partridge,Hope S. Rugo	2024	4
4	AI ‐guided histopathology predicts brain metastasis in lung cancer patients The Journal of Pathology ·Daryn Rahardja,Mark A. Watson,Cory T. Bernadt,Steven H. Lin,Chieh‐Yu Lin,Jon H. Ritter,Alexander S. Wein,Simon Mahler,Athina Skordi,Ramaswamy Govindan,Changhuei Yang,Richard J. Côté	2024	13
5	Automatic detection of circulating tumor cells and cancer associated fibroblasts using deep learning Scientific Reports ·Cheng Shen,Siddarth Rawal,Y.Sheena Mary,Daryn Rahardja,Ashutosh Agarwal,Mark A. Watson,Richard J. Côté,Changhuei Yang	2023	19
6	Non-Small Cell Lung Cancer Epigenomes Exhibit Altered DNA Methylation in Smokers and Never-Smokers Genomics Proteomics & Bioinformatics ·Farzaneh Namazifar,Erica C. Pehrsson,Xiaoyun Xing,Mark A. Watson,Siddhartha Devarakonda,Ramaswamy Govindan,Ting Wang	2023	7
7	Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in Pancreatic Cancer Cancer Immunology Research ·冯佩兰,John Baer,W. A. Harvey,FokHan Leung Fran Scott,Brett L. Knolhoff,Graham D. Hogg,Natalie L. Kingston,Liang‐I Kang,Varintra E. Lander,Jingqin Luo,I. Pelnier,Mark A. Watson,Rebecca Aft,Ryan C. Fields,William G. Hawkins,David G. DeNardo	2023	13
8	Developmental Pathways Are Epigenetically Reprogrammed during Lung Cancer Brain Metastasis Cancer Research ·Farzaneh Namazifar,Siddhartha Devarakonda,Xiaoyun Xing,H. Josh Jang,Ramaswamy Govindan,Mark A. Watson,Ting Wang	2022	13
9	Cellular and plasma proteomic determinants of COVID-19 and non-COVID-19 pulmonary diseases relative to healthy aging Nature Aging ·Laura Arthur,Ekaterina Esaulova,Denis A. Mogilenko,Nikolaj Beier,Samantha Burdess,Anwesha Laha,Rachel M. Presti,Brian D. Goetz,Mark A. Watson,Charles W. Goss,Christina A. Gurnett,Philip A. Mudd,Courtney Beers,Jane A. O’Halloran,Maxim N. Artyomov	2021	30
10	ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106. Journal of Clinical Oncology ·X. Cynthia,Vera J. Suman,A. Marilyn Leitch,Souzan Sanati,Kiran Vij,Gary Unzeitig,Jeremy Hoog,Mark A. Watson,Olwen Hahn,J. Michael Guenther,Abigail S. Caudle,Travis Dockter,Larissa A. Korde,Anna Weiss,Kelly K. Hunt,Clifford A. Hudis,Eric P. Winer,Ann H. Partridge,Lisa A. Carey,Matthew J. Ellis,(unknown)	2020	27
11	Genomic characterization of HER2-positive breast cancer and response to neoadjuvant trastuzumab and chemotherapy—results from the ACOSOG Z1041 (Alliance) trial Annals of Oncology ·Robert Lesurf,Obi L. Griffith,Malachi Griffith,Jasreet Hundal,Lee Trani,Mark A. Watson,Rebecca Aft,Matthew J. Ellis,eagle,Vera J. Suman,Funda Meric‐Bernstam,A. Marilyn Leitch,Judy C. Boughey,Gary Unzeitig,Aman U. Buzdar,Kelly K. Hunt,Elaine R. Mardis	2017	47
12	Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers Nature Communications ·Christopher A. Miller,Yevgeniy Gindin,Charles Lu,Obi L. Griffith,Malachi Griffith,Dong Shen,Jeremy Hoog,Tiandao Li,David E. Larson,Mark A. Watson,Sherri R. Davies,Kelly K. Hunt,Vera J. Suman,Jacqueline Snider,Thomas Walsh,Graham A. Colditz,Katherine DeSchryver,Richard K. Wilson,Elaine R. Mardis,Matthew J. Ellis	2016	51
13	Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor Clinical Cancer Research ·Jinsheng Yu,Hrishikesh Deshmukh,Jacqueline E. Payton,Christopher Dunham,Bernd W. Scheithauer,Tarık Tihan,Richard A. Prayson,Abhijit Guha,Julia A. Bridge,Rosalie E. Ferner,Guy Lindberg,Cavaleri Rosalba,Ryan J. Emnett,Muhammad Ahmad,David H. Gutmann,Rakesh Nagarajan,Mark A. Watson,Arie Perry	2011	85
14	PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer Cancer Research ·Robert J. Crowder,Chanpheng Phommaly,Tao Yu,Jeremy Hoog,Jingqin Luo,Charles M. Perou,Joel S. Parker,Melinda A. Miller,David G. Huntsman,Lin Li,Jacqueline Snider,Sherri R. Davies,John A. Olson,Mark A. Watson,Anthony J. Saporita,Jason D. Weber,Matthew J. Ellis	2009	174
15	Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer Breast Cancer Research and Treatment ·Matthew J. Ellis,Lin Li,Robert J. Crowder,Tao Yu,Jeremy Hoog,Jacqueline Snider,Sherri R. Davies,Katherine DeSchryver,Dean B. Evans,Jutta Steinseifer,Raj Bandaru,Weihua Liu,Humphrey Gardner,Semiglazov Vf,Mark A. Watson,Kelly K. Hunt,John A. Olson,José Baselga	2009	110
16	Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate Modern Pathology ·Souzan Sanati,Mark A. Watson,Andrea L. Salavaggione,Peter A. Humphrey	2009	38
17	Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies TWIST1 as a Marker of Early Tumor Relapse in Breast Cancer Patients Clinical Cancer Research ·Mark A. Watson,Lourdes R. Ylagan,Kathryn Trinkaus,William E. Gillanders,Michael Naughton,Katherine N. Weilbaecher,Timothy P. Fleming,Rebecca Aft	2007	98
18	Large-Scale Molecular Comparison of Human Schwann Cells to Malignant Peripheral Nerve Sheath Tumor Cell Lines and Tissues Cancer Research ·Shyra J. Miller,Fatima Rangwala,Jon Williams,Peter Ackerman,Sue Kong,Anil G. Jegga,Sérgio Kaiser,Bruce J. Aronow,Silke Frahm,Lan Kluwe,Victor Mautner,Meena Upadhyaya,David Muir,Margaret R. Wallace,Jussara Hagen,Dawn E. Quelle,Mark A. Watson,Arie Perry,David H. Gutmann,Nancy Ratner	2006	158
19	Expression Profiles Provide Insights into Early Malignant Potential and Skeletal Abnormalities in Multiple Endocrine Neoplasia Type 2B Syndrome Tumors Cancer Research ·Sanjay Jain,Mark A. Watson,Mary K. DeBenedetti,Yuji Hiraki,Jeffrey F. Moley,Jeffrey Milbrandt	2004	59
20	Mammaglobin, a mammary-specific member of the uteroglobin gene family, is overexpressed in human breast cancer. PubMed ·Mark A. Watson,Timothy P. Fleming	1996	263

About Mark A. Watson

Mark A. Watson is a scholar working on Cancer Research, Oncology, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 129 papers that have together received 7.2k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (21 papers), Cancer Genomics and Diagnostics (19 papers), Molecular Biology Techniques and Applications (14 papers), RNA modifications and cancer (9 papers), Estrogen and related hormone effects (9 papers), Gene expression and cancer classification (9 papers), Glioma Diagnosis and Treatment (8 papers) and Genetic factors in colorectal cancer (8 papers). The work is most often cited by research in Cancer Research (1.7k citations), Oncology (1.9k citations), Molecular Biology (3.4k citations), Pathology and Forensic Medicine (794 citations) and Pulmonary and Respiratory Medicine (1.4k citations). Mark A. Watson has collaborated with scholars based in United States, Canada and France. Frequent co-authors include Jeffrey Milbrandt, Timothy P. Fleming, David H. Gutmann, Arie Perry, Rakesh Nagarajan, Toshiyuki Araki, John Svaren, Torsten Ehrig, Verónica Luzzi and Peter A. Humphrey. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Cancer Research, Breast Cancer Research and Treatment and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact